systematic_review
    2022

    Recent Advances in the Therapeutic Potential of Emodin for Human Health

    Sharifi-Rad J, Herrera-Bravo J, Kamiloglu S, Petroni K, Mishra AP, Cruz-Martins N

    Published in Biomedicine and Pharmacotherapy

    Methodology

    Narrative review of emodin bioactivity, mechanisms and translational status across metabolic, inflammatory and oncological models.

    Key Findings

    Emodin modulates inflammatory signalling, glucose and lipid metabolism and tumour pathways in preclinical models; clinical translation is limited by low bioavailability and safety concerns.

    Conclusions

    Emodin remains an experimental compound without controlled human efficacy data.

    Limitations

    Narrative review; preclinical evidence only; no risk-of-bias appraisal.

    Supplements Studied

    Emodin
    Compound

    Clinical translation is limited by low bioavailability and safety concerns.

    Study Details

    Year:2022
    Quality Score:4/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.